Discovery of New Inhibitors of Hepatitis C Virus NS3/4A Protease and Its D168A Mutant | ACS Omega
Amino Acid and Peptide‐Based Antiviral Agents - Skwarecki - 2021 - ChemMedChem - Wiley Online Library
Epclusa, INN-sofosbuvir/velpatasvir
Sofosbuvir/Velpatasvir/Voxilaprevir: A Highly Effective Option for Retreatment of Hepatitis C in Difficult-to-treat Patients - Poonam Mathur, Shyamasundaran Kottilil, Eleanor Wilson, 2019
Sofosbuvir/velpatasvir: A promising combination
Real-world cost-effectiveness of pan-genotypic Sofosbuvir-Velpatasvir combination versus genotype dependent directly acting anti-viral drugs for treatment of hepatitis C patients in the universal coverage scheme of Punjab state in India | PLOS ONE
Epclusa (sofosbuvir + velpatasvir)
Frontiers | Drug-drug interactions between antithrombotics and direct-acting antivirals in hepatitis C virus (HCV) patients: A brief, updated report
Cells | Free Full-Text | Hepatitis C Virus Infection: Host–Virus Interaction and Mechanisms of Viral Persistence
Structure-activity relationships of fluorene compounds inhibiting HCV variants - ScienceDirect
Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir | Scientific Reports
Advances in Treatment of Hepatitis C | IntechOpen
Frontiers | Update on Antiviral Strategies Against COVID-19: Unmet Needs and Prospects
Direct-acting antiviral agents for hepatitis C: structural and mechanistic insights | Nature Reviews Gastroenterology & Hepatology
Velpatasvir - an overview | ScienceDirect Topics
Learning the ABC's of Today's Hepatitis C Medications
Evolution of efficacious pangenotypic hepatitis C virus therapies - Ashraf - 2019 - Medicinal Research Reviews - Wiley Online Library
Therapeutics for COVID-19: from computation to practices—where we are, where we are heading to | SpringerLink
Plant Uptake and Metabolism of 2,4-Dibromophenol in Carrot: In Vitro Enzymatic Direct Conjugation | Journal of Agricultural and Food Chemistry
Frontiers | Drug-drug interactions between antithrombotics and direct-acting antivirals in hepatitis C virus (HCV) patients: A brief, updated report
Viruses | Free Full-Text | Overview of HCV Life Cycle with a Special Focus on Current and Possible Future Antiviral Targets
Antivirals for Hepatitis C | Concise Medical Knowledge
Velpatasvir | C49H54N8O8 - PubChem
Hepatitis C Virus Infection Treatment: Recent Advances and New Paradigms in the Treatment Strategies | IntechOpen
Viral Hepatitis C Therapy: Pharmacokinetic and Pharmacodynamic Considerations: A 2019 Update | SpringerLink
Cells | Free Full-Text | Mechanisms Underlying Hepatitis C Virus-Associated Hepatic Fibrosis
